| Literature DB >> 23055807 |
Mara Ribeiro Almeida1, Joana D'Arc Castania Darin, Lívia Cristina Hernandes, Mônica Freiman de Souza Ramos, Lusânia Maria Greggi Antunes, Osvaldo de Freitas.
Abstract
Copaiba oil-resin, extracted from the trunk of Copaifera, and traditionally used in folk medicine in the treatment of various disorders, has been shown to be an effective antiinflamatory, antitumor, antitetanus, antiseptic and anti-blenorrhagea agent. As, there are few studies evaluating its genotoxicity, this aspect of the commercial oil-resin, and its volatile and resinous fractions, were evaluated in mice by comet assay and micronucleus (MN) test. A single dose of oil resin, volatile or resin fractions (500; 1,000 or 2,000 mg/kg b.w.) was administered by gavage. The chemical compositions of Copaiba oil resin and its fractions was analyzed by gas chromatography. According to comet assaying, treatment with either one did not increase DNA damage, and as to MN testing, there was no alteration in the incidence of micronucleated polychromatic erythrocytes. Chromatographic analysis of the oil-resin itself revealed sesquiterpenes, diterpenic carboxylic acid methyl esters and high levels of β-caryophyllene. Thus, it can be assumed that the oil resin and volatile and resinous fractions from the commercial product are not genotoxic or mutagenic.Entities:
Keywords: Copaiba oilresin; comet assay; genotoxicity; micronucleus
Year: 2012 PMID: 23055807 PMCID: PMC3459418 DOI: 10.1590/S1415-47572012005000052
Source DB: PubMed Journal: Genet Mol Biol ISSN: 1415-4757 Impact factor: 1.771
Percentage of DNA in the tail (%DNA tail) and Olive moment obtained from liver cells of mice treated with different doses of oil-resin, and volatile and resinous fractions (500, 1,000 or 2,000 mg/kg b.w.) from commercial Copaiba oil-resin and respective negative, positive (methyl methanesulphonate – MMS, 50 mg/kg b.w., i.p.) and solvent (Tween 20) controls.
| Treatments (mg/kg) | % DNA tail Mean ± SD | Olive moment Mean ± SD |
|---|---|---|
| Negative control | 5.84 ± 0.58 | 4.03 ± 0.95 |
| Solvent control | 8.37 ± 3.85 | 7.05 ± 4.70 |
| Positive control | 28.15 ± 0.75[ | 26.03 ± 3.19[ |
|
| ||
| Oil-resin | ||
| 500 | 4.05 ± 1.31 | 4.41 ± 3.75 |
| 1000 | 4.16 ± 1.63 | 2.05 ± 1.46 |
| 2000 | 5.21 ± 1.80 | 3.09 ± 1.51 |
|
| ||
| Volatile fraction | ||
| 500 | 11.42 ± 4.40 | 10.24 ± 5.26 |
| 1000 | 9.59 ± 4.73 | 8.16 ± 5.72 |
| 2000 | 6.88 ± 2.19 | 4.33 ± 2.03 |
|
| ||
| Resin | ||
| 500 | 10.09 ± 4.66 | 7.42 ± 4.17 |
| 1000 | 8.94 ± 3.01 | 7.11 ± 3.39 |
100 nucleoids were analyzed per animal, with six animals per group.
p < 0.05 compared to negative control.
p < 0.05 compared to solvent control. One way-ANOVA and post-hoc Tukey test.
Frequencies of micronucleated polychromatic erythrocytes (MNPCE) in bone marrow and peripheral blood of mice treated with different doses of oil-resin, and volatile and resinous fractions (500, 1,000 or 2,000 mg/kg b.w.) from commercial Copaiba oil-resin, and respective negative, positive (Doxorubicin, 16 mg/kg b.w., i.p.) and solvent (Tween 20) controls.
| Treatments (mg/kg) | Bone marrow erythrocytes | Peripheral blood erythrocytes | |
|---|---|---|---|
| MNPCE Mean ± SD | PCE/NCE | MNPCE Mean ± SD | |
| Negative control | 3.83 ± 1.78 | 1.47 ± 0.44 | 1.50 ± 1.04 |
| Solvent control | 2.0 ± 1.41 | 1.42 ± 0.27 | 1.50 ± 1.22 |
| Positive control | 31.16 ± 7.90[ | 1.31 ± 0.14 | 14.16 ± 5.11[ |
|
| |||
| Oil-resin | |||
| 500 | 2.83 ± 1.72 | 1.26 ± 0.17 | 1.66 ± 1.50 |
| 1000 | 2.83 ± 0.75 | 1.74 ± 0.68 | 1.16 ± 0.75 |
| 2000 | 2.66 ± 0.81 | 1.48 ± 0.19 | 1.33 ± 1.03 |
|
| |||
| Volatile fraction | |||
| 500 | 2.16 ± 1.16 | 1.51 ± 0.21 | 1.33 ± 1.03 |
| 1000 | 2.66 ± 0.91 | 1.41 ± 0,21 | 0.83 ± 0.70 |
| 2000 | 4.16 ± 1.72 | 1.27 ± 0.33 | 1.33 ± 1.03 |
|
| |||
| Resin fraction | |||
| 500 | 4.66 ± 1.03 | 1.32 ± 0.27 | 2.16 ± 1.16 |
| 1000 | 2.50 ± 1.51 | 1.28 ± 0.12 | 1.83 ± 1.04 |
2,000 PCE were analyzed per animal, with six animals per group.
1,000 PCE were analyzed per animal.
p < 0.05 compared to negative control.
p < 0.05 compared to solvent control. One way-ANOVA and post-hoc Tukey test.
Relative abundance (%) of the constituents of commercial Copaiba oil-resin.
| RIlit | RI | Constituent | Relative peak area (%)
| ||
|---|---|---|---|---|---|
| Oil resin | Volatile fraction | Resin | |||
| 1338 | 1340 | δ-Elemene | 0.38 | 0.65 | |
| 1348 | 1350 | α-Cubebene | 0.22 | 0.47 | |
| 1376 | 1379 | α-Copaene | 2.46 | 4.46 | |
| 1390 | 1391 | β-Elemene | 1.02 | 1.53 | |
| 1398 | 1403 | Cyperene | 0.36 | 0.60 | |
| 1419 | 1423 | β-Caryophyllene ( | 51.78 | 70.01 | |
| 1434 | 1439 | α-Bergamotene ( | 1.07 | 1.58 | |
| 1436 | 1441 | γ-Elemene | 0.92 | 1.19 | |
| 1454 | 1465 | α-Humulene | 8.57 | 10.91 | |
| 1479 | 1483 | γ-Muurolene | 0.23 | 0.56 | |
| 1484 | 1485 | α-Amorphene | 1.14 | 1.35 | |
| 1485 | 1488 | Germacrene D | 1.20 | 1.00 | |
| 1490 | 1493 | β-Selinene | 0.56 | 0.65 | |
| 1498 | 1499 | α-Selinene | 0.53 | 0.30 | |
| 1505 | 1509 | β-Bisabolene | 1.48 | 1.4 | |
| 1523 | 1522 | γ-Cadinene | 1.40 | 1.27 | |
| 1561 | 1565 | Germacrene B | 0.48 | 0.26 | |
| 1572 | 1578 | Caryophyllenyl alchool | 0.63 | 0.27 | |
| 1582 | 1589 | Caryophyllene oxide | 0.32 | 1.42 | |
| 1640 | 1636 | epi-α-Cadinol | 0.15 | ||
| 1644 | 1642 | epi-α-Muurolol | 0.43 | ||
| 1654 | 1651 | α-Cadinol | 0.22 | ||
| Eperuic acid | 0.46 | 0.67 | |||
| Copalic acid | 4.70 | 32.07 | |||
| Kovalenic acid | 0.30 | 0.71 | |||
| Danielic acid | 2.58 | 16.70 | |||
| Pinifolic acid | 0.58 | 1.11 | |||
| Agathic acid | 3.35 | 11.95 | |||
| Hydroxy-copalic acid | 5.08 | 6.19 | |||
| Acetoxy-copalic acid | 4.02 | 26.98 | |||
| Sesquiterpenes hydrocarbons | 78.80 | 98.19 | |||
| Sesquiterpenes oxygenated | 1.75 | 1.69 | |||
| Total sesquiterpenes | 75.55 | 99.88 | |||
| Diterpenes | 21.07 | 96.38 | |||
| Total identified | 96.62 | 99.88 | 96.38 | ||
RI lit = Retention Index. See Adams (2007).
Diterpene acids were analyzed as methyl esters derivatives.